News

Many people think cancer always shows up with dramatic, unmistakable signs. But for women, some of the most common and ...
Coffeville in Jackson raises funds for 3-year-old Milo Larson battling leukemia through their Coffee with a Cause specialty ...
ENDO 2025 featured the latest research on novel therapies for adrenal and neuroendocrine conditions, new data on various ...
Eli Lilly's experimental GLP-1 pill helped people lose about 12% of their body weight, with weight loss plateauing for most patients in the 72-week trial, according to full study results presented at ...
WEIGHT loss injections like Mounjaro and Wegovy are hailed as the “miracle” in obesity treatment. But are they really any ...
Eli Lilly's experimental GLP-1 pill, orforglipron, showed a 12% average weight loss over a 72-week trial, although less effective than Novo Nordisk's Wegovy. The trial involved over 3,000 non-diabetic ...
Over 1,300 women are still dying of breast cancer in Sweden every year. Theodoros Foukakis is trying to understand the tumour ...
The Health department has set up a multidisciplinary team of experts to inquire into the incident wherein a guidewire which was used to put a central line in a woman who underwent thyroidectomy ...
Actors Jin Tae-hyun and Park Si-eun will appear together on KBS2 'Problematic Children in the Rooftop Room'.Actor Jin Tae-hyun, who was diagnosed with thyroid cancer in May and stopped broadcasting ...
The U.S. Food and Drug Administration has sent a letter to Novo Nordisk (NVO) CEO Maziar Mike Doustdar regarding the company’s promotional communication featuring Oprah Winfrey, alleging that the ...
The novel system being used in the study was cleared by the Food & Drug Administration in 2024 for ablation of soft tissue ...
The U.S. Food and Drug Administration (FDA) has determined that a promotional video featuring Zepbound and Mounjaro ...